NCT03713203 - PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 27, 2019

Primary Completion Date

August 27, 2026

Study Completion Date

August 27, 2026

Conditions

Paget Disease of the VulvaPaget Disease, Extramammary

Interventions

DEVICE

pagetex PDT

2 to 4 sessions of PDT treatment during 2.5 hours after application of Metvixia and incubation under occlusive coat.

Trial Locations (1)

RECRUITING

Hôpital Claude Huriez, CHU, Lille